HealthLink Dimensions adds Diaceutics lab data for sharper HCP targeting

HealthLink Dimensions said July 9, 2026, that Diaceutics diagnostic data is now available inside HealthLink Profile for audience creation. The integration is meant to help pharmaceutical teams build more clinically relevant HCP audiences and improve campaign performance across email, paid social and programmatic channels.

Why it matters: - Diagnostic activity data can help pharmaceutical brands identify treating physicians earlier in the patient journey. - HealthLink Dimensions says the added signal can make HCP audiences more clinically relevant and improve engagement in complex and specialty therapeutic areas. - The move expands access to diagnostic-driven audience building for more HealthLink customers.

What happened: - HealthLink Dimensions said July 9, 2026, that data from Diaceutics is now available to HealthLink clients for audience creation through HealthLink Profile. - The integration is designed for pharmaceutical brands and omnichannel teams. - The data can be used across email, paid social and programmatic channels.

The details: - Diaceutics data shows which physicians are seeing relevant diagnostic activity in near real time. - That visibility is intended to help marketers align messages with clinical realities as patients move through care. - HealthLink Dimensions and Diaceutics have worked together for more than three years. - The two companies have used that relationship to help brand teams build more clinically relevant HCP audiences across campaigns. - HealthLink said the integration pairs Diaceutics lab data with its privacy, security and compliance standards. - HealthLink Profile is the company’s verified dataset of U.S. healthcare professionals and is refreshed monthly for accuracy and deliverability. - HealthLink’s activation tools turn that data into real-time HCP outreach across email, paid social and programmatic. - The platform also includes clinical and digital engagement triggers that surface in-market signals as they happen. - HealthLink Dimensions is a member of the Network Advertising Initiative, holds TrustArc privacy certification, maintains SOC 2 Type II attestation and is one of the few openly registered data brokers serving the space. - More information is available at HealthLink Dimensions.

Between the lines: - The integration shows how commercial health data firms are packaging diagnostic signals with audience activation tools to target clinicians more precisely. - The pitch is that better timing and more relevant context can turn outreach from interruption into behavior change. - Diaceutics framed the value as using diagnostic intelligence to build audiences grounded in clinical reality.

What's next: - HealthLink clients can now use the added Diaceutics data as part of their HCP audience strategies. - HealthLink and Diaceutics are likely to keep building around diagnostic-driven activation as pharma teams look for more precise outreach. - The companies did not announce a separate product launch timeline beyond the data availability update.

The bottom line: - HealthLink Dimensions is betting that diagnostic data will help pharma marketers reach clinicians earlier, with messages that better match patient care decisions.